Peter Matzneller (P Matzneller)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Multidrug Resistant

Emergency Department

Top Venues

The Journal of antimicrobial chemotherapy

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Anselm Jorda, Beatrix Wulkersdorfer, Christian Schörgenhofer, Peter Matzneller, Valentin Al Jalali, Martin Bauer, Michael Wölf-Duchek, Edith Lackner, Christoph Dorn, Bernd Jilma, Markus Zeitlinger
Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial. The Journal of antimicrobial chemotherapy 77 (5) (2022)
Perrin Ngougni Pokem, Peter Matzneller, Steven Vervaeke, Xavier Wittebole, Lieven Goeman, Marie Coessens, Eleonora Cottone, Arnaud Capron, Beatrix Wulkersdorfer, Pierre Wallemacq, Johan W Mouton, Anouk E Muller, Markus Zeitlinger, Pierre François Laterre, Paul M Tulkens, Françoise Van Bambeke
Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medications. The Journal of antimicrobial chemotherapy 77 (10) (2022)
Valentin Al Jalali, M Wölfl-Duchek, Max Taubert, Peter Matzneller, E Lackner, C Dorn, A Kratzer, B Wulkersdorfer, Z Österreicher, M Zeitlinger
Plasma and soft tissue pharmacokinetics of ceftolozane/tazobactam in healthy volunteers after single and multiple intravenous infusion: a microdialysis study. The Journal of antimicrobial chemotherapy 76 (9) (2021)
Beatrix Wulkersdorfer, Sebastian G Wicha, Elizaveta Kurdina, Stephan F Carrion Carrera, Peter Matzneller, Valentin Al Jalali, Matthias G Vossen, Sonja Riesenhuber, Edith Lackner, Christoph Dorn, Markus Zeitlinger
Protein binding of clindamycin in vivo by means of intravascular microdialysis in healthy volunteers. The Journal of antimicrobial chemotherapy 76 (8) (2021)
Arindam Pal, Peter Matzneller, Anirudh Gautam, Zoe Österreicher, Beatrix Wulkersdorfer, Birgit Reiter, Thomas Stimpfl, Markus Zeitlinger
Target site pharmacokinetics of doxycycline for rosacea in healthy volunteers is independent of the food effect. British journal of clinical pharmacology 84 (11) (2018)